Catalyst Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Catalyst Pharmaceuticals, Inc.

9 hours	Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies CPRX GlobeNewswire
Jan-05	The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) CPRX GlobeNewswire
Dec-15	Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference CPRX GlobeNewswire
Nov-24	Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference CPRX GlobeNewswire
Nov-19	Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500 CPRX GlobeNewswire
Nov-18	Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference CPRX GlobeNewswire
Nov-05	Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update CPRX GlobeNewswire
Nov-04	Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work CPRX GlobeNewswire
Nov-03	Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference CPRX GlobeNewswire
Oct-22	Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 CPRX GlobeNewswire
Oct-09	Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences CPRX GlobeNewswire
Oct-01	Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program CPRX GlobeNewswire
Aug-28	Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences CPRX GlobeNewswire
Aug-26	UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-25	Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-06	Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update CPRX GlobeNewswire
Aug-06	Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC) CPRX GlobeNewswire
Aug-04	Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors CPRX GlobeNewswire
Jul-22	Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 CPRX GlobeNewswire
Jun-02	Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer CPRX GlobeNewswire
May-07	Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update CPRX GlobeNewswire

Catalyst Pharmaceuticals, Inc.

Recent Articles by Catalyst Pharmaceuticals, Inc.

Upgrade your FINVIZ experience